COM:PROQR
ProQR Therapeutics
- Stock
locale
Netherlandsmarket
STOCKSindustry
Biotechnologywebsite
www.proqr.comcrunchbase
proqr-therapeuticslinkedin
proqr-therapeuticsipo date
Sep 18, 2014
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediate...Show More